carvedilol has been researched along with Injury, Ischemia-Reperfusion in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is an alpha1 and nonselective beta-adrenergic receptor antagonist with antioxidative properties known to protect against reperfusion injury in the heart, brain, and kidneys." | 7.70 | Carvedilol reduces ischaemic skeletal muscle necrosis. ( Hvaal, K; Kirkeby, OJ; Mathisen, SR; Skjeldal, S; Svindland, A, 1999) |
| "Carvedilol treatment decreased the detrimental effects induced by R-IRI." | 5.62 | Quercetin and lithium chloride potentiate the protective effects of carvedilol against renal ischemia-reperfusion injury in high-fructose, high-fat diet-fed Swiss albino mice independent of renal lipid signaling. ( Ibrahim, IAAE; Mahmoud, AAA; Mahmoud, MF; Rezk, AM, 2021) |
| "Treatment with carvedilol significantly decreased plasma creatinine levels after IRI (up to 168 hr) compared to controls (P < 0." | 5.36 | Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress. ( De Velasco, MA; Hayashi, T; Ishii, T; Nishioka, T; Nose, K; Saitou, Y; Uemura, H, 2010) |
| " In addition, factors potentially involved in hepatic ischemia-reperfusion injury, including oxidative stress (malondialdehyde and superoxide anion levels), mitochondrial damage (glutamate dehydrogenase activity), microcirculatory disorders (flow rate and vascular resistance), and adenosine triphosphate (ATP) depletion, were evaluated after reperfusion." | 3.76 | Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. ( Alfany-Fernandez, I; Ben Abdennebi, H; Ben Mosbah, I; Boillot, O; Lojek, A; Mitjavila, MT; Parellada, PP; Peralta, C; Rimola, A; Rodés, J; Roselló-Catafau, J, 2010) |
| "Carvedilol is an alpha1 and nonselective beta-adrenergic receptor antagonist with antioxidative properties known to protect against reperfusion injury in the heart, brain, and kidneys." | 3.70 | Carvedilol reduces ischaemic skeletal muscle necrosis. ( Hvaal, K; Kirkeby, OJ; Mathisen, SR; Skjeldal, S; Svindland, A, 1999) |
| "Carvedilol, a selective alpha(1) and non-selective beta-adrenoceptor antagonist and antioxidant, has been shown to provide significant cardiac protection in animal models of myocardial ischemia." | 3.70 | Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. ( Chen, J; Christopher, TA; Gao, F; Gu, J; Lopez, BL; Lysko, P; Ma, XL; Ohlstein, EH; Ruffolo, RR; Yue, TL, 2000) |
| "Carvedilol treatment decreased the detrimental effects induced by R-IRI." | 1.62 | Quercetin and lithium chloride potentiate the protective effects of carvedilol against renal ischemia-reperfusion injury in high-fructose, high-fat diet-fed Swiss albino mice independent of renal lipid signaling. ( Ibrahim, IAAE; Mahmoud, AAA; Mahmoud, MF; Rezk, AM, 2021) |
| "Treatment with carvedilol significantly decreased plasma creatinine levels after IRI (up to 168 hr) compared to controls (P < 0." | 1.36 | Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress. ( De Velasco, MA; Hayashi, T; Ishii, T; Nishioka, T; Nose, K; Saitou, Y; Uemura, H, 2010) |
| "Carvedilol is a recently introduced drug with multiple action with a non-selective beta-antiadrenergic and selective alpha1-antiadrenergic action used for treatment of mild to medium severe hypertension." | 1.30 | [The effects of Carvedilol, a beta-blocker, in experimental ischemia-reperfusion kidney injury]. ( Bartosíková, L; Drápelová, L; Husek, K; Kuchtícková, S; Necas, J; Pavlícek, V, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Kafadar, MT | 1 |
| Gök, MA | 1 |
| Mohammed, SG | 1 |
| Ibrahim, IAAE | 2 |
| Mahmoud, MF | 2 |
| Mahmoud, AAA | 2 |
| Rezk, AM | 1 |
| Hassan, MI | 1 |
| Ali, FE | 1 |
| Shalkami, AS | 1 |
| Chen, Z | 1 |
| Wu, Y | 1 |
| Duan, J | 1 |
| Zhu, B | 1 |
| Yang, L | 1 |
| Harima, M | 1 |
| Arumugam, S | 1 |
| Wen, J | 1 |
| Pitchaimani, V | 1 |
| Karuppagounder, V | 1 |
| Afrin, MR | 1 |
| Sreedhar, R | 1 |
| Miyashita, S | 1 |
| Nomoto, M | 1 |
| Ueno, K | 1 |
| Nakamura, M | 1 |
| Watanabe, K | 1 |
| Özsoy, AZ | 1 |
| Nursal, AF | 1 |
| Arıcı, A | 1 |
| Bütün, İ | 1 |
| Uysal, M | 1 |
| Irmak Sapmaz, H | 1 |
| Kunt İşgüder, Ç | 1 |
| Yılmaz Doğru, H | 1 |
| Taş, U | 1 |
| Park, KM | 1 |
| Teoh, JP | 1 |
| Wang, Y | 1 |
| Broskova, Z | 1 |
| Bayoumi, AS | 1 |
| Tang, Y | 1 |
| Su, H | 1 |
| Weintraub, NL | 1 |
| Kim, IM | 1 |
| Hayashi, T | 2 |
| Saitou, Y | 2 |
| Nose, K | 2 |
| Nishioka, T | 2 |
| Ishii, T | 2 |
| Uemura, H | 2 |
| Usta, E | 1 |
| Renovanz, M | 1 |
| Mustafi, M | 1 |
| Ziemer, G | 1 |
| Aebert, H | 1 |
| Ben Mosbah, I | 1 |
| Roselló-Catafau, J | 1 |
| Alfany-Fernandez, I | 1 |
| Rimola, A | 1 |
| Parellada, PP | 1 |
| Mitjavila, MT | 1 |
| Lojek, A | 1 |
| Ben Abdennebi, H | 1 |
| Boillot, O | 1 |
| Rodés, J | 1 |
| Peralta, C | 1 |
| De Velasco, MA | 1 |
| Lai, MK | 1 |
| Yamagata, K | 1 |
| Ichinose, S | 1 |
| Tagami, M | 1 |
| Singh, D | 1 |
| Chander, V | 1 |
| Chopra, K | 1 |
| Strosznajder, RP | 1 |
| Jesko, H | 1 |
| Dziewulska, J | 1 |
| Igarashi, N | 1 |
| Nozawa, T | 1 |
| Fujii, N | 1 |
| Suzuki, T | 1 |
| Matsuki, A | 1 |
| Nakadate, T | 1 |
| Igawa, A | 1 |
| Inoue, H | 1 |
| Vacek, L | 1 |
| Husek, K | 2 |
| Christopher, TA | 2 |
| Lopez, BL | 2 |
| Ma, XL | 2 |
| Feuerstein, GZ | 1 |
| Ruffolo, RR | 2 |
| Yue, TL | 2 |
| Necas, J | 1 |
| Bartosíková, L | 1 |
| Drápelová, L | 1 |
| Pavlícek, V | 1 |
| Kuchtícková, S | 1 |
| Hvaal, K | 1 |
| Mathisen, SR | 1 |
| Svindland, A | 1 |
| Kirkeby, OJ | 1 |
| Skjeldal, S | 1 |
| Gao, F | 1 |
| Chen, J | 1 |
| Gu, J | 1 |
| Lysko, P | 1 |
| Ohlstein, EH | 1 |
| Horio, T | 1 |
| Ito, S | 1 |
| Aoyama, M | 1 |
| Takeda, Y | 1 |
| Suzumura, H | 1 |
| Nakata, K | 1 |
| Yamada, Y | 1 |
| Suzuki, S | 1 |
| Fukutomi, T | 1 |
| Itoh, M | 1 |
23 other studies available for carvedilol and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Effects of Carvedilol on liver ischemia-reperfusion injury in rats.
Topics: Animals; Carvedilol; Caspase 3; Glutathione; Liver; Rats; Rats, Wistar; Reperfusion Injury; Tumor Ne | 2022 |
Carvedilol protects against hepatic ischemia/reperfusion injury in high-fructose/high-fat diet-fed mice: Role of G protein-coupled receptor kinase 2 and 5.
Topics: Animals; Carvedilol; Diet, High-Fat; Fructose; G-Protein-Coupled Receptor Kinase 2; G-Protein-Couple | 2019 |
Quercetin and lithium chloride potentiate the protective effects of carvedilol against renal ischemia-reperfusion injury in high-fructose, high-fat diet-fed Swiss albino mice independent of renal lipid signaling.
Topics: Animals; Apoptosis; Carvedilol; Cytoprotection; Diet, High-Fat; Drug Synergism; Fructose; Kidney; Li | 2021 |
Role of TLR-4/IL-6/TNF-α, COX-II and eNOS/iNOS pathways in the impact of carvedilol against hepatic ischemia reperfusion injury.
Topics: Adrenergic Antagonists; Animals; Anti-Inflammatory Agents; Carvedilol; Cyclooxygenase 2; Interleukin | 2021 |
Carvedilol exerts myocardial protection via regulation of AMPK-mTOR-dependent autophagy?
Topics: AMP-Activated Protein Kinases; Autophagy; Carvedilol; Humans; Reperfusion Injury; Signal Transductio | 2019 |
Effect of carvedilol against myocardial injury due to ischemia-reperfusion of the brain in rats.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Blood Pressure; Brain; Carbazoles; Carvedilol; Hear | 2015 |
Effects of carvedilol on an ischemia/reperfusion model: Biochemical, histopathological and immunohistochemical evaluation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; bcl-2-Associated X Protein; Carbazoles; | 2016 |
Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Carbazoles; Carvedilol; Cell Line; Cells, Cultured; | 2016 |
Efficacy of carvedilol for ischemia/reperfusion-induced oxidative renal injury in rats.
Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Creatinine; Kidney; Kidney Function Tests; | 2008 |
Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation--ischemia and apoptosis studies.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Apoptosis; Biopsy; Calcium; Carbazoles; Carvedilo | 2010 |
Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
Topics: Adenosine; Adenosine Triphosphate; Adenylate Kinase; Adrenergic beta-Antagonists; Allopurinol; Anima | 2010 |
Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antihypertensive Agents; Apoptosis; Carbazoles; Carvedilol; Cr | 2010 |
Editorial comment to carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress.
Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Epithelial Cells; Humans; Kidney Tubules; | 2010 |
Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antioxidants; Carbazoles; Carvedilol; Cell Death; Cell Hypoxia; Cells, Cultured | 2004 |
Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats.
Topics: Animals; Antioxidants; Carbazoles; Carvedilol; Glutathione; Kidney; Kidney Function Tests; Lipid Per | 2004 |
Effect of carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Carbazoles; Carvedilol; Cell Survival; D | 2005 |
Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury.
Topics: Adrenergic beta-Antagonists; Animals; Autoradiography; Carbazoles; Carvedilol; Fatty Acids; Iodobenz | 2006 |
[Protective effect of carvedilol on renal circulation and tissue injury in reperfusion of ischemic kidneys in rats].
Topics: Animals; Blood Flow Velocity; Carbazoles; Carvedilol; Free Radical Scavengers; Kidney; Male; Propano | 1994 |
Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injury.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilol; Endothel | 1998 |
[The effects of Carvedilol, a beta-blocker, in experimental ischemia-reperfusion kidney injury].
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Kidney; Male; Malondialdehyde; Propano | 1997 |
Carvedilol reduces ischaemic skeletal muscle necrosis.
Topics: Adrenergic beta-Antagonists; Animals; Area Under Curve; Blood Pressure; Carbazoles; Carvedilol; Hind | 1999 |
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles | 2000 |
Effect of carvedilol on atrioventricular conduction in the ischemic heart.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bundle of His | 2001 |